facebook linked in twitter youtube instagram

Office Notice

Due to inclement weather conditions, the Raleigh office will be closed today, Jan. 21, 2022.

The LatestView All

Click here to learn more.

February 15, 2022

FinTech and Special Purpose Acquisition Companies (SPACs)

Continuing the FinTech University series, join chair of Nelson Mullins FinTech and Regulation Practice and moderator, Richard Levin, and attorneys Jon Talcott, Andy Tucker, and Peter Strand for this one-hour session, "FinTech and SPACs." Continuing Legal Education (CLE) credit will be sought for all attorneys requesting. Certificates of attendance are available upon request for CPE purposes. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit.

Click here to learn more.

Press Releases

Dec. 9, 2021

Partner Christopher Hanson Joins SCBIO Board

GREENVILLE, S.C. – Partner Christopher Hanson has joined the Board of Directors of SCBIO, a statewide, not-for-profit industry association and economic development organization formed to actively promote, build, support, expand, and convene South Carolina's life sciences industry. Nelson Mullins also is a member of the organization. 

Hanson, based in Greenville, S.C. and Washington, D.C.,  leads the firm’s Food and Drug Administration (FDA) Regulatory Compliance & Litigation practice group. He assists clients with regulatory issues involving medical devices, human and animal drugs, in vitro diagnostics (IVDs), dietary supplements, cosmetics, radiation-emitting electronic products, and clinical laboratories. He has aided clients in consequential interactions with federal, state, and foreign regulatory agencies.

In his advisory practice, his work includes drafting FDA regulatory submissions as well as preparing public comments for agency rulemakings, guidance documents, advisory committees, and public policy venues. He provides strategic advice and regulatory due diligence to support corporate transactions and securities filings in the life sciences space. He also has experience counseling in FDA agency enforcement matters and conducting global internal investigations and audits.

SCBIO is the South Carolina affiliate of the U.S. Biotechnology Innovation Organization (BIO) and the exclusively dedicated advocate and 'voice' for the multifaceted S.C. life sciences industry, according  to the organization. BIO champions biotechnology and its potential to provide better healthcare, enhanced agriculture, and a cleaner and safer environment for people around the world.

Established in 1897, Nelson Mullins is an Am Law 100 firm that has more than 850 attorneys and government relations professionals with offices in 11 states and Washington, DC. For more information on the firm, go to www.nelsonmullins.com.

What's New
Idea Exchange